Form 10-Q Surgery Partners, Inc. For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Surgery Partners (SGRY) PT Lowered to $40 at Jefferies
November 13, 2024 4:03 PM ESTJefferies analyst Brian Tanquilut lowered the price target on Surgery Partners (NASDAQ: SGRY) to $40.00 (from $47.00) while maintaining a Buy rating.
The analyst comments "Our takes post-Q3 release/call: 1) some of the stock's weakness is due to rotation out by... More
Surgery Partners (SGRY) PT Lowered to $31 at Barclays
November 13, 2024 9:44 AM ESTBarclays analyst Andrew Mok lowered the price target on Surgery Partners (NASDAQ: SGRY) to $31.00 (from $32.00) while maintaining a Equalweight rating.
The analyst comments "Free Cash Flow: SGRY has delivered about $36 mn free cash flow YTD, representing about 25% of the informal 2024 target... More
